Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Sanguine Diagnostics And Therapeutics, Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

Sanguine Diagnostics And Therapeutics, Inc.

Private

Won 7 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: ECGMLSHGH4X6

Founded: —Source: [GOV]
Headquarters: Omaha, NebraskaSource: [GOV]
Country: United StatesSource: [GOV]
Headcount: 0Source: [GOV]

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

Sanguine Diagnostics And Therapeutics, Inc. has been awarded 7 US Small Business Innovation Research (SBIR/STTR) contracts totalling $3,761,807 between 2014 and 2019. These are non-dilutive federal research grants, not equity financing. The company is based in Omaha, Nebraska.

Funding rounds

6 rounds

6 rounds · latest SBIR Phase I award (HHS), Mar 2019

Investors

No investors recorded yet for Sanguine Diagnostics And Therapeutics, Inc..

Add an investor

People

Leadership

WADE M JUNKERPrincipal investigatorSince 2019Source: [GOV]

AARON R SASSONPrincipal investigatorSince 2014Source: [GOV]

Acquisitions

Sanguine Diagnostics And Therapeutics, Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Sanguine Diagnostics And Therapeutics, Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Stage

Seed

Sector

Healthcare